Biome Grow (CSE:BIO) has launched its campaign on the Investing News Network’s Cannabis channel.

Biome Grow is a Canadian cannabis company focused on building the next conglomerate for the country’s growing industry. The company is deploying a business model that focuses on local consumers and developing a regional presence in the underserved markets of Atlantic Canada. Through the company’s subsidiaries, Biome is working to establish unique consumer, regional and B2B brands, products and services that are overseen by a centralized management team.

An integral part of Biome Grow’s business model is the placement of their wholly-owned subsidiaries, which service currently underserved regions in Canada. The company’s most advanced-stage subsidiary, Highland Grow, operates a 6,500-square-foot facility in Antigonish, Nova Scotia. Focused on consumer education, the company has partnered with St. Francis Xavier University for an R&D initiative and has acquired an educational virtual reality platform, Weed VR, which will be deployed in all jurisdictions Biome Grow serves, including Ontario and Newfoundland and Labrador.

Biome Grow’s company highlights include the following:

  • Canadian cannabis market is expected to exceed $7 billion in sales in 2019 after the market is legalized.
  • Global cannabis market is expected to reach $146.4 billion by 2025.
  • Licensed Producer in Nova Scotia
  • Late-stage ACMPR license applicants in Ontario and Newfoundland and Labrador.
  • Capitalizing on the untapped cannabis markets in Atlantic Canada.
  • Global expansion opportunities.
  • Approximately 390,000 square feet of cannabis production and research space between multiple facilities once operational.
  • Cannabis education platform to be launched with Weed VR in all jurisdictions.
  • R&D multidisciplinary collaboration partnership with St. Francis Xavier University in Nova Scotia.
  • Highly respected and experienced management team.

Click here to see the educational profile for Biome Grow (CSE:BIO) and to request an investor presentation.

Revive Therapeutics Ltd. (“Revive”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce the appointment of Dr. Joel Moody, MD, MPH, DTM&H, as a medical and clinical advisor to the Company to assist in the expansion of clinical studies in Canada and the clinical data analysis on the ongoing U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild-moderate COVID-19.

“We would like to welcome Dr. Moody as a medical and clinical advisor to our team and we look forward to his contributions in our ongoing FDA Phase 3 clinical study as well as expanding our COVID-19 studies in Canada,” said Michael Frank, CEO of Revive. “Dr. Moody’s experience in clinical epidemiology, data analysis and research are key to our FDA Phase 3 study as we gather clinical data from patients enrolled.”

Keep reading... Show less

– FinCanna Capital Corp. (CSE:CALI) (OTCQB:FNNZF), based in Vancouver, BC today announced that Andriyko Herchak, CEO, will present live at on December 3 rd .

Keep reading... Show less

First-of-its-kind trial in Canada will pave the way for expanded MDMA-assisted treatment to support patients with posttraumatic stress disorder

Keep reading... Show less

Multi-year partnership designates BioSteel as new official sports drink of Philadelphia 76ers team, Training Complex, and the presenting partner of 76ers Training Camp

BioSteel today announced a multi-year deal with the Philadelphia 76ers, making the sports hydration company the official sports drink of the team. BioSteel will also serve as a partner of the Philadelphia 76ers Training Complex, and the presenting partner for 76ers Training Camp, which begins next week.

Keep reading... Show less

Achievements with Scalability and Compatibility Pave Way for Next Phase of Advancement

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) is excited to announce that the Company’s holding, Arcology, a cluster-computing powered AI blockchain ecosystem with unlimited scalability, has updated its working roadmap in response to its Testnet 1.0 results

Keep reading... Show less